Americore (AMCOF) Funding Launched. Looks Like Good Entry Point.

All Systems Go? A recently completed Magnetometer survey sends a strong signal to investors that the company is advancing its project in a disciplined, data-driven...

Society Pass (SOPA) Files Chapter 11.

So sad.. No 8k filing yet (05/13/2026), just a news story. 8K SEC filing page SEC (allow time to load) 05/14/26 SOPA 8k filing 5/13/2026 NUTR 8K filing What...

When Secure Communications is Absolutely Paramount to Mission Success. Sekur Private Data (SWISF).

Sekur (SWISF) $0.05 Headed to Huge Special Ops Military Convention in Tampa FL. Will Demonstrate it's "SekurVoice" Solution, to Special Ops Buyers, Designed for...

Cabaletta (CABA) Surges 44% on Massive Volume Spike.

Biotech 12 Pack Off to Nice Start.. Cabaletta up 35%, GeoVax up 75%, and Replimune up 62%. All since late April! Biotech Stock Review is...

GeoVax (GOVX) Surges 51% on Massive Volume Spike.

MonkeyPox and Gedeptin Related News Spark New Investor Interest. MARKET BRIEF On a quiet Wednesday afternoon, the 29th, while we were nearing completion of an updated...

All Bases Loaded. Home Run Hitter Ray Palumbo, former Deputy Commanding General of the United...

Four of the Most Powerful and Well Recognized, US Government Intelligence and Defense Experts, Have Officially Joined Forces With Tiny Sekur Private Data (SWISF)...

GeoVax (GOVX) Reports 2025 Year-End Financial Results and Provides Business Update

LIVE QUOTE Pivotal Phase 3 Trial for GEO-MVA (Mpox/Smallpox Vaccine) Scheduled to Initiate During the Second Half of This Year ATLANTA, GA - April 15, 2026 (NEWMEDIAWIRE)...

Danger Will Robinson: the NIPAH Virus with a 40-75% Death Rate Lurks.

Report: Nipah Virus Vaccine: Need, Development Landscape, and $3 Billion Market Opportunity Report: Nipah Virus Vaccine: Need, Development Landscape, and $3 Billion Market Opportunity Click to...

Adding Cabaletta (CABA) $3.07, GeoVax (GOVX) $1.14, PolyPid (PYPD) $4.68 and Replimune (REPL) $2.17...

Biotech 12 Pack Watch List to be Released. Biotech Stock Review is Back! Timing Feels Perfect. 4 Companies Added to Watch List. In 2020, we Released...

REPORT OpenWorld: The Contrarian’s Case.

Adding to Watch List. Why VerifyMe's (VRME) $0.90 Reverse Merger Deserves a Second Look. Or First Look for Some. LIVE QUOTE RECENT NEWS VerifyMe Reports Fourth Quarter...

Latest article

Fusion Energy Starter.

VC-Funded Fusion Energy Companies "The fastest way to deploy fusion and I believe one of my forecasts is we will replace every coal and natural...

Party Time at UniQure (QURE)! From $8.86 to $47.21, up 432%.

I. No Bells, No Baskets. UniQure (QURE) $47 up Huge. Still Not Out Of The Woods! II. Replimune (REPL) $11.23. Gains 28% in Sympathy with...

We’re Up 360% in Six Weeks. Replimune (REPL).

That's a Gain of $604 Million, and That Ain't Bad! Six brokerage firms downgraded Replimune (REPL), around the same time we added it to...